Overview

This trial is active, not recruiting.

Condition obese patients
Treatment progression of diabetes
Sponsor University of Pavia
Start date October 2016
End date November 2016
Trial size 1000 participants
Trial identifier NCT02934737, 20160004418

Summary

Obese patients will be enrolled from 2006 to 2014. The progression of diabetes mellitus will be observed (if any). Anthropometric and biochemical parameters will be evaluated.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective

Primary Outcomes

Measure
Progression of diabetes
time frame: 8 years
Anthropometric parameters
time frame: 8 years
Anthropometric parameters
time frame: 8 years
Markers of progression of diabetes
time frame: 8 years
Markers of progression of diabetes
time frame: 8 years

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

Inclusion Criteria: - Obesity (body mass index >/= 30 Kg/m2 - Normal blood glucose (glycemia < 100 mg/dl) Exclusion Criteria: - No exclusion criteria

Additional Information

Official title Role of Some Markers in the Progression of Diabetes in Obese Patients: a 8-year Observational Study
Principal investigator Giuseppe Derosa, MD, PhD, FESC
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by University of Pavia.